Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis: Other Tumors

Correlations between FDG-PET/CT findings and pathological risk in thymic epithelial lesions

Hideki Otsuka, Yoichi Otomi, Hayato Nose, Kaori Terazawa, Yamato Kunikane, Naomi Morita and Masafumi Harada
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 590;
Hideki Otsuka
1Radiology, Tokushima University, Tokushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoichi Otomi
1Radiology, Tokushima University, Tokushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hayato Nose
1Radiology, Tokushima University, Tokushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaori Terazawa
1Radiology, Tokushima University, Tokushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yamato Kunikane
1Radiology, Tokushima University, Tokushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naomi Morita
1Radiology, Tokushima University, Tokushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masafumi Harada
1Radiology, Tokushima University, Tokushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

590

Objectives The aim of this study was to evaluate the correlation between pathological risk and fluorodeoxyglucose (FDG) uptake, CT findings and clinical stage of FDG-positive thymic epithelial lesions.

Methods Twenty-nine (15 males, 14 females, 27-84 years old) who underwent FDG-PET/CT examinations before any treatment were enrolled. All lesions were FDG-positive and pathologically confirmed as thymic epithelial tumors. The pathological types were confirmed according to the World Health Organization categories, and classified into three subgroups of low risk (LR), high risk (HR) and thymic carcinoma (Ca). We analyzed the maximum standardized uptake value (SUVmax) using FDG-PET, and the size and shape of the lesions, and evaluated the calcification, degenerative changes/necrosis and contrast enhancement pattern on CT. Masaoka stages were also determined.

Results Nine patients were classified as LR, 10 as HR and 10 as Ca. The mean SUVmax values were: LR, 3.6; HR, 3.9; Ca, 7.7. The SUVmax of Ca was significantly higher than those of LR and HR. The mean sizes (mm) were: LR, 38; HR, 60; Ca, 77. The tumor size of Ca was significantly larger than that of LR. The number of patients with the different stages were: Stage I: LR 6, HR 1, Ca 0, Stage II: LR 2, HR 2, Ca 1, Stage III: LR 1, HR 3, Ca 3, Stage IVa: LR 0, HR 4, Ca 0, Stage IVb: LR 0, HR 0, Ca 6. No calcification was seen in LR. All 10 Ca patients had degenerative/necrotic change.

Conclusions Thymic carcinomas have very high FDG uptake, large size, heterogeneous strong contrast enhancement on CT and advanced clinical stage. Low risk thymomas have slight to moderate FDG uptake, round/oval shaped, small size, smooth margin, and can be differentiated from carcinomas by these findings. High risk thymomas have various metabolic and morphologic patterns, and sometimes mimic low risk thymomas or carcinomas. In advanced stage, FDG-PET/CT may be useful for clinical staging, because it can clearly demonstrate pleural dissemination, lymph nodes metastases and distant metastasis such as those to the liver and bone

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Correlations between FDG-PET/CT findings and pathological risk in thymic epithelial lesions
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Correlations between FDG-PET/CT findings and pathological risk in thymic epithelial lesions
Hideki Otsuka, Yoichi Otomi, Hayato Nose, Kaori Terazawa, Yamato Kunikane, Naomi Morita, Masafumi Harada
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 590;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Correlations between FDG-PET/CT findings and pathological risk in thymic epithelial lesions
Hideki Otsuka, Yoichi Otomi, Hayato Nose, Kaori Terazawa, Yamato Kunikane, Naomi Morita, Masafumi Harada
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 590;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis: Other Tumors

  • Dual-time-point FDG-PET/CT for the evaluation of thymic epithelial tumors
  • Can PET-CT scan be performed under zoledronic acid treatment or is it necessary to withdraw?
  • Differential diagnosis of pulmonary artery lesions using 18F-FDG PET/CT
Show more Oncology: Clinical Diagnosis: Other Tumors

Other Tumors (Clinical Oncology)

  • Differential diagnostic value of SPECT/spiral CT in patients with spinal lesions using 99mTc-MDP
  • FDG-PET/CT for staging of peritoneal carcinomatosis before peritonectomy and hyperthermic intraperitoneal chemotherapy - Is there an additional benefit of contrast-enhanced CT?
Show more Other Tumors (Clinical Oncology)

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire